Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$236M |
| 2 |
AbbVie
ABBV
|
+$159M |
| 3 |
Sysco
SYY
|
+$136M |
| 4 |
FedEx
FDX
|
+$135M |
| 5 |
Coca-Cola
KO
|
+$126M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$306M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
Union Pacific
UNP
|
+$193M |
| 4 |
Alibaba
BABA
|
+$177M |
| 5 |
Walmart
WMT
|
+$174M |
Sector Composition
| 1 | Healthcare | 13.17% |
| 2 | Financials | 11.79% |
| 3 | Technology | 11.03% |
| 4 | Consumer Staples | 10.42% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Prosperity Bancshares
PB
$6.44B
| $7.57M | 0.02% |
+154,091
| New | +$7.57M |
|
1102
TTEC Holdings
TTEC
$179M
| $7.56M | 0.02% |
282,200
-11,400
| -4% | -$305K |
|
1103
HealthStream
HSTM
$866M
| $7.56M | 0.02% |
346,558
+112,474
| +48% | +$2.45M |
|
1104
Bank OZK
OZK
$5.91B
| $7.55M | 0.02% |
172,617
+13,373
| +8% | +$585K |
|
|
TAST
1105
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $7.55M | 0.02% |
634,700
+320,300
| +102% | +$3.81M |
|
|
GTY
1106
Getty Realty Corp
GTY
$1.61B
| $7.54M | 0.02% |
483,083
+176,421
| +58% | +$2.75M |
|
1107
Zurn Elkay Water Solutions
ZWS
$7.92B
| $7.54M | 0.02% |
921,314
-42,351
| -4% | -$346K |
|
|
NSU
1108
DELISTED
Nevsun Resources Ltd.
NSU
| $7.5M | 0.02% |
2,584,600
+19,974
| +0.8% | +$57.9K |
|
1109
Dr. Reddy's Laboratories
RDY
$12.3B
| $7.49M | 0.02% |
586,000
-234,500
| -29% | -$3M |
|
1110
Black Hills Corp
BKH
$4.33B
| $7.48M | 0.02% |
181,000
+75,900
| +72% | +$3.14M |
|
1111
Magna International
MGA
$13.2B
| $7.46M | 0.02% |
155,384
-174,200
| -53% | -$8.36M |
|
|
ALX
1112
Alexander's
ALX
$1.25B
| $7.44M | 0.02% |
19,900
+1,700
| +9% | +$636K |
|
1113
KBR
KBR
$6.38B
| $7.44M | 0.02% |
446,700
+392,400
| +723% | +$6.54M |
|
1114
Gilat Satellite Networks
GILT
$629M
| $7.43M | 0.02% |
2,105,400
+9,000
| +0.4% | +$31.8K |
|
1115
Dynavax Technologies
DVAX
$1.14B
| $7.43M | 0.02% |
302,551
+276,300
| +1,053% | +$6.78M |
|
1116
Labcorp
LH
$23.2B
| $7.42M | 0.02% |
79,623
-143,405
| -64% | -$13.4M |
|
|
INFI
1117
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $7.42M | 0.02% |
877,500
-320,850
| -27% | -$2.71M |
|
|
EVHC
1118
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $7.4M | 0.02% |
67,134
+44,455
| +196% | +$4.9M |
|
|
EXAR
1119
DELISTED
Exar Corporation
EXAR
| $7.38M | 0.02% |
1,240,968
-59,576
| -5% | -$354K |
|
1120
Middlesex Water
MSEX
$971M
| $7.38M | 0.02% |
309,600
+86,198
| +39% | +$2.05M |
|
|
INFN
1121
DELISTED
Infinera Corporation Common Stock
INFN
| $7.38M | 0.02% |
377,200
-547,700
| -59% | -$10.7M |
|
|
UNT
1122
DELISTED
UNIT Corporation
UNT
| $7.37M | 0.02% |
654,414
+317,014
| +94% | +$3.57M |
|
1123
CGI
GIB
$21B
| $7.37M | 0.02% |
203,482
+101,982
| +100% | +$3.69M |
|
|
DMND
1124
DELISTED
DIAMOND FOODS, INC.
DMND
| $7.36M | 0.02% |
238,500
+103,100
| +76% | +$3.18M |
|
|
ITCI
1125
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.33M | 0.02% |
+183,091
| New | +$7.33M |
|